Your browser doesn't support javascript.
loading
Effects of the oral, direct factor Xa inhibitor edoxaban on routine coagulation assays, lupus anticoagulant and anti-Xa assays.
Hillarp, Andreas; Strandberg, Karin; Baghaei, Fariba; Fagerberg Blixter, Inger; Gustafsson, Kerstin M; Lindahl, Tomas L.
Affiliation
  • Hillarp A; a Department of Clinical Chemistry and Transfusion Medicine , Halland County Hospital , Halmstad , Sweden.
  • Strandberg K; b Department of Clinical Chemistry , University and Regional Laboratories Region Skåne , Malmö , Sweden.
  • Baghaei F; c Department of Medicine , Coagulation Centre, Sahlgrenska University Hospital , Gothenburg , Sweden.
  • Fagerberg Blixter I; d Department of Clinical Chemistry and Transfusion Medicine , Institute of Biomedicine , The Sahlgrenska Academy, University of Gothenburg , Gothenburg , Sweden.
  • Gustafsson KM; e Department of Clinical and Experimental Medicine , Linköping University , Linköping , Sweden.
  • Lindahl TL; e Department of Clinical and Experimental Medicine , Linköping University , Linköping , Sweden.
Scand J Clin Lab Invest ; 78(7-8): 575-583, 2018.
Article in En | MEDLINE | ID: mdl-30278787
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Thiazoles / Thromboembolism / Blood Coagulation / Blood Coagulation Tests / Factor Xa Inhibitors Limits: Humans Language: En Journal: Scand J Clin Lab Invest Year: 2018 Document type: Article Affiliation country: Sweden
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pyridines / Thiazoles / Thromboembolism / Blood Coagulation / Blood Coagulation Tests / Factor Xa Inhibitors Limits: Humans Language: En Journal: Scand J Clin Lab Invest Year: 2018 Document type: Article Affiliation country: Sweden